These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30915656)

  • 1. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
    Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
    Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of Financial Incentives to Mailed Outreach for Promoting Colorectal Cancer Screening: A Systematic Review and Meta-analysis.
    Facciorusso A; Demb J; Mohan BP; Gupta S; Singh S
    JAMA Netw Open; 2021 Aug; 4(8):e2122581. PubMed ID: 34432010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
    Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
    CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to increase colorectal cancer screening adherence in low-income settings within the United States: A systematic review and meta-analysis.
    Rubin L; Okitondo C; Haines L; Ebell M
    Prev Med; 2023 Jul; 172():107522. PubMed ID: 37137414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing Mailed Colorectal Cancer Fecal Screening Tests in Real-World Primary Care Settings: Promising Implementation Practices and Opportunities for Improvement.
    Hohl SD; Maxwell AE; Sharma KP; Sun J; Vu TT; DeGroff A; Escoffery C; Schlueter D; Hannon PA
    Prev Sci; 2024 Apr; 25(Suppl 1):124-135. PubMed ID: 36952143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science.
    Gupta S; Barnes A; Brenner AT; Campbell J; Davis M; English K; Hoover S; Kim K; Kobrin S; Lance P; Mishra SI; Oliveri JM; Reuland DS; Subramanian S; Coronado GD
    Prev Chronic Dis; 2023 Dec; 20():E112. PubMed ID: 38060411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.
    Dougherty MK; Brenner AT; Crockett SD; Gupta S; Wheeler SB; Coker-Schwimmer M; Cubillos L; Malo T; Reuland DS
    JAMA Intern Med; 2018 Dec; 178(12):1645-1658. PubMed ID: 30326005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach.
    Lee B; Keyes E; Rachocki C; Grimes B; Chen E; Vittinghoff E; Ladabaum U; Somsouk M
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1326-1333.e4. PubMed ID: 34280552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
    Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
    JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
    Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
    Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial.
    Jean-Jacques M; Kaleba EO; Gatta JL; Gracia G; Ryan ER; Choucair BN
    Ann Fam Med; 2012; 10(5):412-7. PubMed ID: 22966104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Behavioral Economics Principles Improves Participation in Mailed Outreach for Colorectal Cancer Screening.
    Bakr O; Afsar-Manesh N; Raja N; Dermenchyan A; Goldstein NJ; Shu SB; May FP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00115. PubMed ID: 31972609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.